Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Ponti

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Nature Clinical Practice. Oncology|August 30, 2008
The impact of histopathologic diagnosis on the proper management of testis neoplasmsGiovanni Ponti, Maurilio Ponzoni, Andrés Jm Ferreri, et al.
Journal of Hematology & Oncology|August 8, 2009
Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case reportNorma Malavasi, Giovanni Ponti, Roberta Depenni, et al.
Journal of Clinical Laboratory Analysis|June 1, 2021
COVID-19 spreading across world correlates with C677T allele of the methylenetetrahydrofolate reductase (MTHFR) gene prevalenceGiovanni Ponti, Lorenza Pastorino, Marco Manfredini, et al.
Melanoma Research|October 1, 2013
Fluorescence in-situ hybridization and dermoscopy in the assessment of controversial melanocytic tumorsGiovanni Ponti, Cristel Ruini, Daniela Massi, et al.
The Journal of Investigative Dermatology|July 11, 2006
Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomasGiovanni Ponti, Lorena Losi, Monica Pedroni, et al.
European Journal of Human Genetics : EJHG|January 31, 2013
Clinical utility gene card for: Gorlin syndrome--update 2013Lorenzo Lo Muzio, Lorenza Pastorino, Sonja Levanat, et al.
Anticancer Research|December 1, 2017
<i>BRAF</i>, <i>NRAS</i> and <i>C-KIT</i> Advanced Melanoma: Clinico-pathological Features, Targeted-Therapy Strategies and SurvivalGiovanni Ponti, Marco Manfredini, Stefano Greco, et al.
Dermatology (Basel, Switzerland)|June 2, 2012
Variegated dermoscopy of in situ melanomaStefania Seidenari, Sara Bassoli, Stefania Borsari, et al.
Critical Reviews in Clinical Laboratory Sciences|July 17, 2023
Hereditary breast and ovarian cancer: from genes to molecular targeted therapiesGiovanni Ponti, Carmine De Angelis, Rosamaria Ponti, et al.
Future Oncology (London, England)|August 8, 2018
Dabrafenib-trametinib combination in 'field-practice': an Italian experienceRoberta Depenni, Francesco De Rosa, Stefano Greco, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Nature Clinical Practice. Oncology|August 30, 2008
The impact of histopathologic diagnosis on the proper management of testis neoplasmsGiovanni Ponti, Maurilio Ponzoni, Andrés Jm Ferreri, et al.
Journal of Hematology & Oncology|August 8, 2009
Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case reportNorma Malavasi, Giovanni Ponti, Roberta Depenni, et al.
Journal of Clinical Laboratory Analysis|June 1, 2021
COVID-19 spreading across world correlates with C677T allele of the methylenetetrahydrofolate reductase (MTHFR) gene prevalenceGiovanni Ponti, Lorenza Pastorino, Marco Manfredini, et al.
Melanoma Research|October 1, 2013
Fluorescence in-situ hybridization and dermoscopy in the assessment of controversial melanocytic tumorsGiovanni Ponti, Cristel Ruini, Daniela Massi, et al.
The Journal of Investigative Dermatology|July 11, 2006
Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomasGiovanni Ponti, Lorena Losi, Monica Pedroni, et al.
European Journal of Human Genetics : EJHG|January 31, 2013
Clinical utility gene card for: Gorlin syndrome--update 2013Lorenzo Lo Muzio, Lorenza Pastorino, Sonja Levanat, et al.
Anticancer Research|December 1, 2017
<i>BRAF</i>, <i>NRAS</i> and <i>C-KIT</i> Advanced Melanoma: Clinico-pathological Features, Targeted-Therapy Strategies and SurvivalGiovanni Ponti, Marco Manfredini, Stefano Greco, et al.
Dermatology (Basel, Switzerland)|June 2, 2012
Variegated dermoscopy of in situ melanomaStefania Seidenari, Sara Bassoli, Stefania Borsari, et al.
Critical Reviews in Clinical Laboratory Sciences|July 17, 2023
Hereditary breast and ovarian cancer: from genes to molecular targeted therapiesGiovanni Ponti, Carmine De Angelis, Rosamaria Ponti, et al.
Future Oncology (London, England)|August 8, 2018
Dabrafenib-trametinib combination in 'field-practice': an Italian experienceRoberta Depenni, Francesco De Rosa, Stefano Greco, et al.
Pageof 10